切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2021, Vol. 15 ›› Issue (01) : 73 -76. doi: 10.3877/cma.j.issn.1674-3946.2021.01.021

所属专题: 文献

论著

改良经胸入路腔镜甲状腺切除术的临床效果及安全性研究
李全1,(), 张景华1, 宋冀涛1, 杨小华1   
  1. 1. 062552 河北任丘,华油总医院二部医院 普通外科
  • 收稿日期:2020-04-10 出版日期:2021-02-10
  • 通信作者: 李全

Clinical analysis of the safety and clinical outcome of modified endoscopic thyroidectomy via transthoracic approach

Quan Li1,(), Jinghua Zhang1, Jitao Song1, Xiaohua Yang1   

  1. 1. Department of General Surgery, the 2nd Branch of Huayou General Hospital, Renqiu, Hebei 062552, China
  • Received:2020-04-10 Published:2021-02-10
  • Corresponding author: Quan Li
  • Supported by:
    Natural science basic research plan of Hebei province(2018JM7067); Application of new medical and health technology in the mining area of north China oilfield(2019-HB-G0203)
引用本文:

李全, 张景华, 宋冀涛, 杨小华. 改良经胸入路腔镜甲状腺切除术的临床效果及安全性研究[J/OL]. 中华普外科手术学杂志(电子版), 2021, 15(01): 73-76.

Quan Li, Jinghua Zhang, Jitao Song, Xiaohua Yang. Clinical analysis of the safety and clinical outcome of modified endoscopic thyroidectomy via transthoracic approach[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2021, 15(01): 73-76.

目的

探究经胸入路腔镜甲状腺切除术中不使用膨胀剂的临床效果。

方法

将2017年6月至2019年12月接受腔镜下甲状腺切除术的100例患者采用随机数字法分为两组,每组50例。膨胀液组使用膨胀液来建立手术操作空间,剥离器组采用自制改良皮下剥离器。使用统计学软件SPSS 24.0分析,围手术期指标、生命体征、疼痛评分等计量资料采用(±s)表示,组间比较采用独立样本t检验;术后并发症等计数资料采用χ2检验。P<0.05为检验标准。

结果

两组患者均成功完成手术,无术中并发症。剥离器组在手术用时、引流时间及引流量均优于膨胀液组(P<0.05);在术中出血量、住院时间、生命体征变化、术后6 h、 12 h及24 h的疼痛评分的比较中,两组间差异均无统计学意义(P>0.05)。剥离器组术后并发症发生率为12%,明显少于膨胀液组28%(P<0.05)。

结论

腔镜下经胸入路甲状腺切除术不使用膨胀剂安全可行,且能显著减少手术时间,可在临床推广。

Objective

To investigate the safety and clinical outcome of modified endoscopic thyroidectomy via transthoracic approach without expandsion.

Methods

A total of 100 patients who received endoscopic thyroidectomy were enrolled into present study, including 50 cases in the expansion fluid group and 50 cases in the stripper group. Patients in the expansion fluid group were treated by using expansion fluid, while patients in the stripper group were treated by using stripper without expansion fluid. SPSS 24.0 software were used for statistical analysis. Measurement data such as perioperative indexes、indexes of vital signs、 pain scores were expressed as (±s) and were analyzed by using independent sample t test. Count data such as postoperative complications were analyzed by using χ2 test. A P value of <0.05 was considered as statistically significant difference.

Results

Patients in both two groups receiced successful operation, without intraoperative complications. The operation time、 drainage time and volume in the stripper group were better those that of the expansion fluid group respectively (P<0.05). There were no statistically significant differences between the two groups in terms of intraoperative blood loss, length of hospital stay, changes in vital signs before and after the establishment of endoscopic space, pain scores at 6h, 12h and 24h after surgery (P>0.05). The incidence of postoperative complications of 12% in the stripper group was significantly better than 28% in the expansion fluid group (P<0.05).

Conclusion

Endoscopic transthoracic thyroidectomy without expandsion fluid is safe and feasible, and could significantly reduce the operation time, which is worthy of clinical promotion.

表1 100例经胸入路腔镜甲状腺切除患者术中不同疗法两组临床基线资料[(±s),例]
图1 自制改良皮下剥离器(平头开钝刃)
表2 100例经胸入路腔镜甲状腺切除患者术中不同疗法两组患者围术期指标比较(±s)
表3 100例经胸入路腔镜甲状腺切除患者术中两组患者建立腔镜空间前后生命体征差值(±s)
表4 100例经胸入路腔镜甲状腺切除患者术中不同疗法两组患者术后VAS评分比较(±s)
表5 100例经胸入路腔镜甲状腺切除患者术中不同疗法两组患者术后并发症发生率比较(例)
[1]
江宏伟,王翠,周勇.全腔镜手术治疗甲状腺微小乳头状癌的疗效分析[J/CD].中华普外科手术学杂志(电子版),2019,13(6): 631-633.
[2]
中华医学会外科学分会.甲状腺手术切口入路、缝合技术与缝合材料选择中国专家共识(2018版)[J].中国实用外科杂志,2019,39(1): 34-38.
[3]
Razavi CR, Tufano RP, Russell JO.Completion thyroidectomy via the transoral endoscopic vestibular approach[J]. Gland Surg, 2018, 7(Suppl 1): S77-S79.
[4]
Battoo AJ, Haji AG, Sheikh ZA,et al.Efficacy of Drainless Total Thyroidectomy in Intrathyroidal Lesions of Thyroid[J]. Int Arch Otorhinolaryngol, 2018, 22(3): 256-259.
[5]
Gagner M.Endoscopic subtotal parathyroidectomy in patients with primary hyperparathyroidism[J].Br J Surg,1996,83(6): 875.
[6]
Park J-O, Kim M-R, Kim D-H,et al.Transoral endoscopic thyroidectomy via the trivestibular route[J].Ann Surg Treat Res,2016,91(5): 269-272.
[7]
Hijazi DM, Addas FA, Alghanmi NM,et al. An Enlarged Goiter Presenting with a Rare Diffuse Lipomatosis of the Thyroid Gland[J]. Am J Case Rep,2018,19: 808-811.
[8]
Lavazza M, Inversini DDI, Dionigi G,et al.Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA) with Standardized Neural Monitoring: Tips, Value, and Limits[J]. Journal of the American College of Surgeons, 2017, 225(4): e41.
[9]
Shivani V, Sasha-Ann E.SUN-602 A Case of Primary Squamous Cell Carcinoma of the Thyroid Gland[J]. Journal of the Endocrine Society, 2019, 30(4): e602.
[10]
王平,燕海潮.腔镜甲状腺手术系列报道之手术空间的建立与维持[J].中国普通外科杂志,2016,25(11): 1531-1535.
[11]
王平,燕海潮.腔镜技术在甲状腺微小乳头状癌治疗中应用[J].中国实用外科杂志,2016,36(5): 517-520.
[12]
Witzel K, Hellinger A, Kaminski C,et al.Endoscopic thyroidectomy:the transoral approach[J].Gland Surg,2016,5(3): 336-341.
[13]
Lee DY, Baek SK, Jung KY.Endoscopic thyroidectomy: retroauricular approach[J].Gland Surg,2016,5(3): 327-335.
[14]
Xiang D, Xie LQ, Li ZY,et al.Endoscopic thyroidectomy along with bilateral central neck dissection (ETBC) increases the risk of transient hypoparathyroidism for patients with thyroid carcinoma[J].Endocrine,2016,53(3): 747-753.
[15]
Jin H, Fan JR, Liao K,et al. A propensity score matching study between ultrasound-guided percutaneous microwave ablation and conventional thyroidectomy for benign thyroid nodules treatment[J]. International Journal of Hyperthermia,2018,35(1): 232-238.
[16]
Yue W-W, Wang S-R, Lu F,et al.Radiofrequency ablation vs. microwave ablation for patients with benign thyroid nodules: a propensity score matching study[J].Endocrine,2017,55(2): 485-495.
[17]
Zhu YQ, Zhang MB.Jin Z,et al.Solid benign thyroid nodules (>10 ml): a retrospective study on the efficacy and safety of sonographically guided ethanol ablation combined with radiofrequency ablation[J].Int J Hyperthermia,2020,37(1): 157-167.
[18]
Zhu YQ, Jin Z, Zhang Y,et al. [Anhydrous Ethanol Improves Efficiency of Radiofrequency Ablation for the Treatment of Benign Thyroid Nodules:A Prospective Randomized Controlled Trial][J].Zhongguo Yi Xue Ke Xue Yuan Xue Bao,2020,42(3): 331-337.
[1] 朴成林, 蓝炘, 司振铎, 李强, 冯健, 安峰铎, 冷建军. 胰十二指肠切除联合肝切除术疗效分析:附5例报告(附视频)[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 363-367.
[2] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[3] 王伟伟, 费建平, 王璋瑜. 不同手术空间建立方法的经口腔前庭入路腔镜甲状腺术对比研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 84-87.
[4] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[5] 许月芳, 刘旺, 曾妙甜, 郭宇姝. 多粘菌素B和多粘菌素E治疗外科多重耐药菌感染临床疗效及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 700-703.
[6] 何羽. 腔镜微创手术治疗分化型甲状腺癌的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 456-458.
[7] 宋红霞, 吴玩呈. 内镜下甲状腺手术切口入路发展的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 470-472.
[8] 张卫锋, 张天翼, 赵正维, 王海强, 尹逊亮. VE /VCO2 斜率对肺癌肺叶切除术后心血管并发症的预测意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 725-730.
[9] 杨轲, 丁增巴姆, 马静, 李盼盼, 陈婷. 全程无缝隙肺康复训练在单孔胸腔镜肺叶切除术中的临床应用[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 801-804.
[10] 张璇, 高杨, 房雅君, 姚艳玲. 保护性机械通气在肺癌胸腔镜肺段切除术中的临床应用[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 563-567.
[11] 任甜甜, 张玉慧, 祁玲霞, 朱梅冬, 胡佳. 多学科疼痛管理对胸腔镜肺叶切除术后胸痛及应激反应的影响分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 630-633.
[12] 蔡剑桥, 蒋雷. 单孔胸腔镜与开胸双袖式肺叶切除治疗非小细胞肺癌对比[J/OL]. 中华胸部外科电子杂志, 2024, 11(04): 225-230.
[13] 王嘉巍, 张广健, 杜昊楠, 余宸傲, 张佳. 混合现实技术在肺结节手术中的应用进展[J/OL]. 中华胸部外科电子杂志, 2024, 11(04): 254-259.
[14] 陈小科, 吴晗, 丁征平. 胸腔镜下右肺上叶前段切除术[J/OL]. 中华胸部外科电子杂志, 2024, 11(04): 261-261.
[15] 沈海锋, 吕方伊, 顾海华, 常志博, 陈盈, 王苹莉, 吴祖群, 邱福铭, 姚杰, 范军强. 局部进展期肺癌新辅助治疗后胸腔镜袖式肺叶切除术——浙江大学医学院附属第二医院2014—2023年56例回顾性分析[J/OL]. 中华胸部外科电子杂志, 2024, 11(03): 158-166.
阅读次数
全文


摘要